New oxygen drug tested for stroke safety

NCT ID NCT04677777

Completed Disease control Sponsor: Prolong Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a drug called PP-007 in 24 people having an acute ischemic stroke. The drug is designed to carry oxygen to the brain. Researchers checked if adding it to standard treatments like clot-busting drugs or clot removal was safe. The goal was to see how the body handled the drug and watch for side effects like bleeding or heart issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

Baptist Health Miami Cardiac & Vascular Institute (MCVI)

Miami, Florida, 33176, United States
Baptist Health Research Institute

Jacksonville, Florida, 32207, United States
Emory University School of Medicine

Atlanta, Georgia, 30303, United States
Mercy Health - St. Vincent Medical Center

Toledo, Ohio, 43608, United States
Oregon Stroke Center at Oregon Health & Science University (OHSU)

Portland, Oregon, 97239, United States
Saint Luke's Hospital

Kansas City, Missouri, 64111, United States
UPMC Stroke Institute

Pittsburgh, Pennsylvania, 15213, United States
University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.